StonvexLoading…
StonvexStonvexStonvexCore line items from XMTR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $686.63M | $545.53M | $463.41M | $380.92M |
Operating Income | $-45.52M | $-56.15M | $-73.58M | $-77.09M |
Net Income | $-61.75M | $-50.40M | $-67.47M | $-79.06M |
EPS (Diluted) | Not available | $-1.03 | $-1.41 | $-1.68 |
Total Assets | $703.72M | $680.13M | $707.39M | $734.11M |
Total Liabilities | $426.98M | $364.53M | $376.97M | $362.31M |
Cash & Equivalents | $15.00M | $22.23M | $53.42M | $65.66M |
Free Cash Flow OCF − CapEx | $-24.09M | $-33.48M | $-48.36M | $-76.22M |
Shares Outstanding | Not available | 49.08M | 47.91M | 47.16M |